Phase IV studies are typically conducted by the pharmaceutical companies that developed the drug, often in collaboration with academic institutions, hospitals, and other healthcare providers. These studies are usually overseen by regulatory agencies like the FDA in the United States or the EMA in Europe to ensure that the treatment remains safe and effective.
